KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Short-term Investments (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Short-term Investments for 5 consecutive years, with $23.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 154106.67% year-over-year to $23.1 million, compared with a TTM value of $23.1 million through Dec 2025, up 154106.67%, and an annual FY2025 reading of $23.1 million, up 154106.67% over the prior year.
  • Short-term Investments was $23.1 million for Q4 2025 at Clover Health Investments, up from $1.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $279.1 million in Q1 2021 and bottomed at $15000.0 in Q4 2024.
  • Average Short-term Investments over 5 years is $59.6 million, with a median of $14.8 million recorded in 2023.
  • The sharpest move saw Short-term Investments tumbled 99.78% in 2024, then surged 154106.67% in 2025.
  • Year by year, Short-term Investments stood at $21.1 million in 2021, then surged by 796.78% to $189.5 million in 2022, then plummeted by 96.36% to $6.9 million in 2023, then crashed by 99.78% to $15000.0 in 2024, then soared by 154106.67% to $23.1 million in 2025.
  • Business Quant data shows Short-term Investments for CLOV at $23.1 million in Q4 2025, $1.8 million in Q3 2025, and $1.8 million in Q2 2025.